As of the latest SEC filings, Spyre Therapeutics, Inc. (SYRE) is held by 235 institutional funds. The largest fund shareholder is SMALLCAP World Fund Inc (SMCWX), holding an estimated $121,696,234.92 in market value, representing 0.15% of its portfolio.
Funds holding Spyre Therapeutics, Inc. (SYRE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SYRE
- CIK:
- 0001636282
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.15% | $121,696,234.92 | 2,412,693 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $111,908,605.12 | 2,218,648 | Mar 31, 2026 | May 28, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.12% | $97,555,497.05 | 2,268,205 | Feb 28, 2026 | Apr 24, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.12% | $85,019,696.84 | 1,685,561 | Mar 31, 2026 | May 28, 2026 |
|
FBTIX
Fidelity Advisor Biotechnology Fund
|
MF | Fidelity | 3.33% | $63,414,425.40 | 851,772 | Apr 30, 2026 | Jun 26, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.69% | $57,901,254.00 | 777,720 | Apr 30, 2026 | Jun 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.17% | $54,971,720.95 | 738,371 | Apr 30, 2026 | Jun 26, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.73% | $53,948,404.64 | 1,069,556 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.40% | $43,083,073.80 | 854,145 | Mar 31, 2026 | May 28, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.65% | $40,429,400.00 | 940,000 | Feb 28, 2026 | Apr 24, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.05% | $38,369,354.92 | 760,693 | Mar 31, 2026 | May 28, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 1.06% | $30,524,500.00 | 410,000 | Apr 30, 2026 | Jun 26, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.12% | $28,908,139.26 | 672,126 | Feb 28, 2026 | Apr 24, 2026 |
|
FCDTX
Fidelity Stock Selector Small Cap Fund
|
MF | Fidelity | 0.41% | $28,539,290.75 | 383,335 | Apr 30, 2026 | Jun 26, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.67% | $28,538,620.70 | 383,326 | Apr 30, 2026 | Jun 26, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.12% | $25,453,834.12 | 591,812 | Feb 28, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.30% | $24,156,169.96 | 478,909 | Mar 31, 2026 | May 28, 2026 |
|
FSOPX
Fidelity Series Small Cap Opportunities Fund
|
MF | Fidelity | 0.43% | $21,839,684.15 | 293,347 | Apr 30, 2026 | Jun 26, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.16% | $19,055,122.32 | 377,778 | Mar 31, 2026 | May 28, 2026 |
|
FIKNX
Fidelity Small Cap Value Fund
|
MF | Fidelity | 0.36% | $18,371,579.80 | 246,764 | Apr 30, 2026 | Jun 26, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.32% | $17,287,998.53 | 401,953 | Feb 28, 2026 | Apr 24, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 0.77% | $16,725,500.48 | 331,592 | Mar 31, 2026 | May 29, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 1.58% | $16,379,000.00 | 220,000 | Apr 30, 2026 | Jun 24, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.04% | $15,328,462.93 | 356,393 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.10% | $14,680,130.19 | 341,319 | Feb 28, 2026 | Apr 28, 2026 |
Advertisement (320x50)